Share on StockTwits

Clinigen Group PLC (LON: CLIN) was the recipient of a ratings changes during the seven days:

  • Clinigen Group PLC had its price target raised by analysts at Investec from GBX 497 ($8.22) to GBX 512 ($8.47). They now have a “buy” rating on the stock.
  • Clinigen Group PLC had its “buy” rating reaffirmed by analysts at Numis Securities Ltd. They now have a GBX 650 ($10.76) price target on the stock.
  • Clinigen Group PLC had its “buy” rating reaffirmed by analysts at N+1 Singer. They now have a GBX 439 ($7.26) price target on the stock.
  • Clinigen Group PLC had its price target raised by analysts at Peel Hunt from GBX 690 ($11.42) to GBX 710 ($11.75). They now have a “buy” rating on the stock.

Clinigen Group PLC (LON:CLIN) traded up 0.84% during mid-day trading on Monday, hitting GBX 442.6884. The stock had a trading volume of 223,963 shares. Clinigen Group PLC has a 52-week low of GBX 354.92 and a 52-week high of GBX 690.00. The stock’s 50-day moving average is GBX 385.4 and its 200-day moving average is GBX 465.8.

Clinigen Group plc (LON:CLIN) is a specialty pharmaceuticals and services business company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.